| 1 | [SID26662276] | Active | Potency | 10 | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction [AID1461, Type: confirmatory] | NPSR1 gene product [Homo sapiens] [gi:46395496] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction | | AID | 1461 | | BioAssay type | confirmatory | | Target | NPSR1 gene product [Homo sapiens] [gi:46395496] | | PubMed | | | Data Table |  |
|
| 2 | [SID26662276] | Active | Potency | 10 | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction [AID1461, Type: confirmatory] | NPSR1 gene product [Homo sapiens] [gi:46395496] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction | | AID | 1461 | | BioAssay type | confirmatory | | Target | NPSR1 gene product [Homo sapiens] [gi:46395496] | | PubMed | | | Data Table |  |
|
| 3 | [SID26662276] | Active | Potency | 12.5893 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 4 | [SID26662276] | Active | Potency | 14.1254 | qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent) [AID485341, Type: confirmatory] | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent) | | AID | 485341 | | BioAssay type | confirmatory | | Target | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] | | PubMed | | | Data Table |  |
|
| 5 | [SID26662276] | Active | Potency | 21.3313 | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) [AID588342, Type: confirmatory] | Luciferase [Photinus pyralis] [gi:160794] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Active | | Potency | 21.3313 [uM] | | BioAssay | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) | | AID | 588342 | | BioAssay type | confirmatory | | Target | Luciferase [Photinus pyralis] [gi:160794] | | PubMed | | | Data Table |  |
|
| 6 | [SID26662276] | Active | Potency | 22.3872 | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 7 | [SID26662276] | Active | Potency | 22.3872 | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 8 | [SID26662276] | Active | Potency | 22.3872 | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 9 | [SID26662276] | Active | Potency | 22.3872 | qHTS of Nrf2 Activators [AID624171, Type: confirmatory] | Nrf2 [Homo sapiens] [gi:693842] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS of Nrf2 Activators | | AID | 624171 | | BioAssay type | confirmatory | | Target | Nrf2 [Homo sapiens] [gi:693842] | | PubMed | | | Data Table |  |
|
| 10 | [SID26662276] | Active | CC50 | 22.63 | Vero 76 Cytoxicity Assay for VEEV Compounds [AID588719, Type: confirmatory] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Active | | CC50 | 22.63 [uM] | | BioAssay | Vero 76 Cytoxicity Assay for VEEV Compounds | | AID | 588719 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID26662276] | Active | Potency | 39.8107 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 12 | [SID26662276] | Active | Potency | 39.8107 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 13 | [SID26662276] | Active | Potency | 79.4328 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Active | | Potency | 79.4328 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 14 | [SID26662276] | Active | Potency | 79.4328 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Active | | Potency | 79.4328 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 15 | [SID26662276] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of G-protein signaling 4 (RGS4) [AID463165, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of G-protein signaling 4 (RGS4) | | AID | 463165 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 16 | [SID26662276] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of G-protein signaling 4 (RGS4) [AID463165, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of G-protein signaling 4 (RGS4) | | AID | 463165 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 17 | [SID26662276] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of G-protein signaling 4 (RGS4) [AID463165, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of G-protein signaling 4 (RGS4) | | AID | 463165 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 18 | [SID26662276] | Active | | | Validation assay for identification of compounds that inhibit the regulator of G-protein signaling 4 (RGS4) [AID492999, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Active | | BioAssay | Validation assay for identification of compounds that inhibit the regulator of G-protein signaling 4 (RGS4) | | AID | 492999 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 19 | [SID26662276] | Active | | | Validation assay for identification of compounds that inhibit the regulator of G-protein signaling 4 (RGS4) [AID492999, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Active | | BioAssay | Validation assay for identification of compounds that inhibit the regulator of G-protein signaling 4 (RGS4) | | AID | 492999 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 20 | [SID26662276] | Active | | | Validation assay for identification of compounds that inhibit the regulator of G-protein signaling 4 (RGS4) [AID492999, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Active | | BioAssay | Validation assay for identification of compounds that inhibit the regulator of G-protein signaling 4 (RGS4) | | AID | 492999 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 21 | [SID26662276] | Active | Potency | | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) [AID652105, Type: confirmatory] | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [gi:18266879] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Active | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) | | AID | 652105 | | BioAssay type | confirmatory | | Target | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha [gi:18266879] | | PubMed | | | Data Table |  |
|
| 22 | [SID26662276] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 23 | [SID26662276] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 24 | [SID26662276] | Active | | | Aqueous Solubility from MLSMR Stock Solutions [AID1996, Type: other] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Active | | BioAssay | Aqueous Solubility from MLSMR Stock Solutions | | AID | 1996 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID26662276] | Active | | | 384-well Z-Lyte format Hck-Nef inhibitor HTS run at the PMLSC [AID463187, Type: screening] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Active | | BioAssay | 384-well Z-Lyte format Hck-Nef inhibitor HTS run at the PMLSC | | AID | 463187 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID26662276] | Active | | | uHTS identification of inhibitors of NadD in a Colorimetric assay [AID602399, Type: screening] | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Active | | BioAssay | uHTS identification of inhibitors of NadD in a Colorimetric assay | | AID | 602399 | | BioAssay type | screening | | Target | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] | | PubMed | | | Data Table |  |
|
| 27 | [SID26662276] | Active | | | Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction [AID2629, Type: screening] | LANA [Human herpesvirus 8] [gi:139472804] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Active | | BioAssay | Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction | | AID | 2629 | | BioAssay type | screening | | Target | LANA [Human herpesvirus 8] [gi:139472804] | | PubMed | | | Data Table |  |
|
| 28 | [SID26662276] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 29 | [SID26662276] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 30 | [SID26662276] | Inactive | Potency | 35.4813 | qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK) [AID1722, Type: confirmatory] | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Inactive | | Potency | 35.4813 [uM] | | BioAssay | qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK) | | AID | 1722 | | BioAssay type | confirmatory | | Target | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] | | PubMed | | | Data Table |  |
|
| 31 | [SID26662276] | Inactive | EC50 | 75 | Fluorescence Polarization Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of the LANA Histone H2A/H2B Interaction [AID435023, Type: confirmatory] | LANA [Human herpesvirus 8] [gi:139472804] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Inactive | | EC50 | 75 [uM] | | BioAssay | Fluorescence Polarization Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of the LANA Histone H2A/H2B Interaction | | AID | 435023 | | BioAssay type | confirmatory | | Target | LANA [Human herpesvirus 8] [gi:139472804] | | PubMed | | | Data Table |  |
|
| 32 | [SID26662276] | Inactive | | | uHTS for Small Molecule Inhibitiors of Epstein-Barr Virus Inhibitors [AID1085, Type: screening] | BZLF2 [Human herpesvirus 4 type 2] [gi:139424501] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Inactive | | BioAssay | uHTS for Small Molecule Inhibitiors of Epstein-Barr Virus Inhibitors | | AID | 1085 | | BioAssay type | screening | | Target | BZLF2 [Human herpesvirus 4 type 2] [gi:139424501] | | PubMed | | | Data Table |  |
|
| 33 | [SID26662276] | Inactive | | | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set [AID588499, Type: Literature] | botulinum neurotoxin type A [Clostridium botulinum A str. ATCC 3502] [gi:148378801] |   View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Inactive | | BioAssay | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | | AID | 588499 | | BioAssay type | Literature | | Target | botulinum neurotoxin type A [Clostridium botulinum A str. ATCC 3502] [gi:148378801] | | PubMed | 16604538 | | Data Table |  |
|
| 34 | [SID26662276] | Inactive | | | Fluorescent Biochemical Primary HTS to Identify Inhibitors of P. aeruginosa PvdQ acylase Measured in Biochemical System Using Plate Reader and Imaging Combination - 2091-01_Inhibitor_SinglePoint_HTS_Activity [AID488965, Type: screening] | pvdQ gene product [Pseudomonas aeruginosa LESB58] [gi:218891639] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Inactive | | BioAssay | Fluorescent Biochemical Primary HTS to Identify Inhibitors of P. aeruginosa PvdQ acylase Measured in Biochemical System Using Plate Reader and Imaging Combination - 2091-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488965 | | BioAssay type | screening | | Target | pvdQ gene product [Pseudomonas aeruginosa LESB58] [gi:218891639] | | PubMed | | | Data Table |  |
|
| 35 | [SID26662276] | Inactive | | | Mycobacterium tuberculosis BioA enzyme inhibitor Measured in Biochemical System Using Plate Reader - 2163-01_Inhibitor_SinglePoint_HTS_Activity [AID602481, Type: screening] | bioA [Mycobacterium tuberculosis UT205] [gi:378544807] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Inactive | | BioAssay | Mycobacterium tuberculosis BioA enzyme inhibitor Measured in Biochemical System Using Plate Reader - 2163-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 602481 | | BioAssay type | screening | | Target | bioA [Mycobacterium tuberculosis UT205] [gi:378544807] | | PubMed | | | Data Table |  |
|
| 36 | [SID26662276] | Inactive | | | Fluorescence polarization to screen for inhibitor that competite the binding of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity [AID588549, Type: screening] | FATTY-ACID-CoA LIGASE FADD28 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) [Mycobacterium tu [gi:1781172] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Inactive | | BioAssay | Fluorescence polarization to screen for inhibitor that competite the binding of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 588549 | | BioAssay type | screening | | Target | FATTY-ACID-CoA LIGASE FADD28 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) [Mycobacterium tu [gi:1781172] | | PubMed | | | Data Table |  |
|
| 37 | [SID26662276] | Inactive | | | Primary biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase [AID1527, Type: screening] | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Inactive | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase | | AID | 1527 | | BioAssay type | screening | | Target | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] | | PubMed | | | Data Table |  |
|
| 38 | [SID26662276] | Inactive | | | Primary biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase [AID1527, Type: screening] | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Inactive | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase | | AID | 1527 | | BioAssay type | screening | | Target | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] | | PubMed | | | Data Table |  |
|
| 39 | [SID26662276] | Inactive | | | Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) [AID493008, Type: screening] | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Inactive | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) | | AID | 493008 | | BioAssay type | screening | | Target | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] | | PubMed | | | Data Table |  |
|
| 40 | [SID26662276] | Inactive | | | Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) [AID493244, Type: screening] | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Inactive | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) | | AID | 493244 | | BioAssay type | screening | | Target | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] | | PubMed | | | Data Table |  |
|
| 41 | [SID26662276] | Inactive | | | MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity [AID652197, Type: screening] | ERAP1 protein [Homo sapiens] [gi:21315078] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Inactive | | BioAssay | MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652197 | | BioAssay type | screening | | Target | ERAP1 protein [Homo sapiens] [gi:21315078] | | PubMed | | | Data Table |  |
|
| 42 | [SID26662276] | Inactive | | | MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity [AID652197, Type: screening] | ERAP1 protein [Homo sapiens] [gi:21315078] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Inactive | | BioAssay | MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 652197 | | BioAssay type | screening | | Target | ERAP1 protein [Homo sapiens] [gi:21315078] | | PubMed | | | Data Table |  |
|
| 43 | [SID26662276] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of TLR9-MyD88 binding. [AID504734, Type: screening] | toll-like receptor 9 [Homo sapiens] [gi:194068499] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of TLR9-MyD88 binding. | | AID | 504734 | | BioAssay type | screening | | Target | toll-like receptor 9 [Homo sapiens] [gi:194068499] | | PubMed | | | Data Table |  |
|
| 44 | [SID26662276] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of TLR9-MyD88 binding. [AID504734, Type: screening] | toll-like receptor 9 [Homo sapiens] [gi:194068499] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of TLR9-MyD88 binding. | | AID | 504734 | | BioAssay type | screening | | Target | toll-like receptor 9 [Homo sapiens] [gi:194068499] | | PubMed | | | Data Table |  |
|
| 45 | [SID26662276] | Inactive | | | Primary cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel ML3 (TRPML3) [AID1448, Type: screening] | MCOLN3 protein [Homo sapiens] [gi:38174238] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel ML3 (TRPML3) | | AID | 1448 | | BioAssay type | screening | | Target | MCOLN3 protein [Homo sapiens] [gi:38174238] | | PubMed | | | Data Table |  |
|
| 46 | [SID26662276] | Inactive | | | Single concentration confirmation of uHTS inhibitor hits from NadD in a Colorimetric assay [AID624309, Type: screening] | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Inactive | | BioAssay | Single concentration confirmation of uHTS inhibitor hits from NadD in a Colorimetric assay | | AID | 624309 | | BioAssay type | screening | | Target | hypothetical protein SA1422 [Staphylococcus aureus subsp. aureus N315] [gi:15927174] | | PubMed | | | Data Table |  |
|
| 47 | [SID26662276] | Inactive | | | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set [AID588501, Type: Literature] | lethal factor [Bacillus anthracis str. A2012] [gi:21392848] |   View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Inactive | | BioAssay | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | | AID | 588501 | | BioAssay type | Literature | | Target | lethal factor [Bacillus anthracis str. A2012] [gi:21392848] | | PubMed | 16604538 | | Data Table |  |
|
| 48 | [SID26662276] | Inactive | | | Inhibitors of Y. pestis Topo-I using cleavage product accumulation Measured in Biochemical System Using Plate Reader - 2123-01_Inhibitor_SinglePoint_HTS_Activity [AID504884, Type: screening] | DNA topoisomerase I [Yersinia pestis CO92] [gi:115347926] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Inactive | | BioAssay | Inhibitors of Y. pestis Topo-I using cleavage product accumulation Measured in Biochemical System Using Plate Reader - 2123-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504884 | | BioAssay type | screening | | Target | DNA topoisomerase I [Yersinia pestis CO92] [gi:115347926] | | PubMed | | | Data Table |  |
|
| 49 | [SID26662276] | Inactive | IC50 | | Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents [AID1903, Type: confirmatory] | large T antigen [Simian virus 40] [gi:297591903] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents | | AID | 1903 | | BioAssay type | confirmatory | | Target | large T antigen [Simian virus 40] [gi:297591903] | | PubMed | | | Data Table |  |
|
| 50 | [SID26662276] | Inactive | | | qHTS of Yeast-based Assay for SARS-CoV PLP [AID485353, Type: confirmatory] | orf1ab polyprotein (pp1ab) [SARS coronavirus] [gi:30124074] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 26662276 | | CID | 54688360 | | Outcome | Inactive | | BioAssay | qHTS of Yeast-based Assay for SARS-CoV PLP | | AID | 485353 | | BioAssay type | confirmatory | | Target | orf1ab polyprotein (pp1ab) [SARS coronavirus] [gi:30124074] | | PubMed | | | Data Table |  |
|